Review Article

Patient-Controlled Analgesia (PCA): Intravenous Administration (IV-PCA) versus Oral Administration (Oral-PCA) by Using a Novel Device (PCoA® Acute) for Hospitalized Patients with Acute Postoperative Pain—A Comparative Retrospective Study

Table 2

Cross-cohort comparison of patients’ continuous variables by T-test for independent samples.

Control-IV-PCATest-Oral-PCA value (T-test)
NMeanStdMinMaxNMeanStdMinMax

Age (years)6159.8916.1421.0091.004455.1411.223.0087.000.078
BMI (kg/m2)6125.724.2016.7034.304426.795.5118.8044.800.260
PCA intervention (days)612.300.591.004.00442.360.871.004.000.650
Hospitalization duration (days)617.544.543.0022.00445.592.352.0015.000.01

Initial NRS at rest613.261.940.008.00443.772.440.0010.000.235
Initial NRS in movement615.742.001.0010.00445.662.180.0010.000.848
End NRS at rest611.661.440.007.00441.501.500.007.000.59
End NRS in movement613.692.080.0010.00442.821.790.006.000.027
NRS score reduction in rest61−1.611.78−8.003.0044−2.272.03−8.001.000.077
NRS score reduction in movement61−2.051.88−6.004.0044−2.841.96−8.001.000.039